Skip to main content

CytoMed Therapeutics Ltd

GDTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001873093

In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.

Members of Congress who traded GDTC

No member of Congress has reported a trade in CytoMed Therapeutics Ltd since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.